1.
Eur J Clin Pharmacol
; 77(6): 933-934, 2021 Jun.
Article
in English
| MEDLINE | ID: covidwho-1002071
Subject(s)
Angioedema , Angiotensin-Converting Enzyme Inhibitors , COVID-19 , Myocardial Infarction , Ramipril , Angioedema/chemically induced , Angioedema/physiopathology , Angioedema/therapy , Angioedema/virology , Angiotensin-Converting Enzyme Inhibitors/administration & dosage , Angiotensin-Converting Enzyme Inhibitors/adverse effects , COVID-19/complications , COVID-19/diagnosis , COVID-19/physiopathology , COVID-19 Nucleic Acid Testing , Cardiovascular Agents/administration & dosage , Coronary Angiography/methods , Drug Substitution/methods , Humans , Male , Middle Aged , Myocardial Infarction/complications , Myocardial Infarction/diagnosis , Myocardial Infarction/drug therapy , Myocardial Infarction/physiopathology , Patient Care Management , Platelet Aggregation Inhibitors/administration & dosage , Ramipril/administration & dosage , Ramipril/adverse effects , SARS-CoV-2 , Treatment Outcome
2.
J Pediatr
; 230: 261-263, 2021 03.
Article
in English
| MEDLINE | ID: covidwho-941348
Subject(s)
Angioedema/virology , COVID-19/complications , Dermatitis, Exfoliative/virology , Foot Dermatoses/virology , Hand Dermatoses/virology , Angioedema/drug therapy , Child , Dermatitis, Exfoliative/drug therapy , Female , Foot Dermatoses/drug therapy , Hand Dermatoses/drug therapy , Histamine Antagonists/therapeutic use , Humans , Pruritus/drug therapy , Pruritus/virology
3.
The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.
Nat Immunol
; 21(10): 1146-1151, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-733513
Subject(s)
Angioedema/immunology , Betacoronavirus/immunology , Coronavirus Infections/immunology , Cytokine Release Syndrome/immunology , Cytokines/metabolism , Pneumonia, Viral/immunology , Angioedema/blood , Angioedema/pathology , Angioedema/virology , Angiotensin-Converting Enzyme 2 , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antiviral Agents/therapeutic use , Biomarkers/blood , COVID-19 , COVID-19 Testing , Clinical Laboratory Techniques/methods , Congresses as Topic , Coronavirus Infections/blood , Coronavirus Infections/diagnosis , Coronavirus Infections/drug therapy , Coronavirus Infections/epidemiology , Cytokine Release Syndrome/blood , Cytokine Release Syndrome/virology , Cytokines/antagonists & inhibitors , Cytokines/blood , Cytokines/immunology , Humans , Internet , Kallikrein-Kinin System/drug effects , Kallikrein-Kinin System/immunology , Pandemics , Peptidyl-Dipeptidase A/metabolism , Pneumonia, Viral/blood , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pulmonary Alveoli/immunology , Pulmonary Alveoli/pathology , SARS-CoV-2 , Severity of Illness Index , Signal Transduction/drug effects , Signal Transduction/immunology , Spike Glycoprotein, Coronavirus/immunology , Spike Glycoprotein, Coronavirus/metabolism , Time Factors , Time-to-Treatment , COVID-19 Drug Treatment
4.
Ann Allergy Asthma Immunol
; 125(5): 600-602, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-693736
Subject(s)
Angioedema/virology , Coronavirus Infections/virology , Diabetes Mellitus, Type 2/virology , Hyperlipidemias/virology , Obesity/virology , Pneumonia, Viral/virology , Respiratory Insufficiency/virology , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/therapeutic use , Adult , Alanine/analogs & derivatives , Alanine/therapeutic use , Ampicillin/therapeutic use , Angioedema/immunology , Angioedema/physiopathology , Angioedema/therapy , Betacoronavirus/drug effects , Betacoronavirus/immunology , Betacoronavirus/pathogenicity , COVID-19 , Coronavirus Infections/immunology , Coronavirus Infections/physiopathology , Coronavirus Infections/therapy , Diabetes Mellitus, Type 2/immunology , Diabetes Mellitus, Type 2/physiopathology , Diabetes Mellitus, Type 2/therapy , Female , Humans , Hydroxychloroquine/therapeutic use , Hyperlipidemias/immunology , Hyperlipidemias/physiopathology , Hyperlipidemias/therapy , Intubation, Intratracheal , Obesity/immunology , Obesity/physiopathology , Obesity/therapy , Pandemics , Pneumonia, Viral/immunology , Pneumonia, Viral/physiopathology , Pneumonia, Viral/therapy , Respiration, Artificial , Respiratory Insufficiency/immunology , Respiratory Insufficiency/physiopathology , Respiratory Insufficiency/therapy , SARS-CoV-2 , Treatment Outcome
5.
Eur Heart J
; 41(34): 3283-3284, 2020 09 07.
Article
in English
| MEDLINE | ID: covidwho-343340